Amedeo Smart

Free Medical Literature Service


 

Amedeo

Neonatology

  Free Subscription

Articles published in
Eur Respir J
    October 2021
  1. SATRELL E, Clemm H, Roksund O, Hufthammer KO, et al
    Development of lung diffusion to adulthood following extremely preterm birth.
    Eur Respir J. 2021 Oct 8. pii: 13993003.04103-2020.
    >> Share

    September 2021
  2. HART K, Cousins M, Watkins WJ, Kotecha SJ, et al
    Association of Early Life Factors with Prematurity-Associated Lung Disease: Prospective Cohort Study.
    Eur Respir J. 2021 Sep 29. pii: 13993003.01766-2021.
    >> Share

    August 2021
  3. ANTIGNY F, Le Ribeuz H, Humbert M, Montani D, et al
    Comment on: Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype.
    Eur Respir J. 2021;58.
    >> Share

  4. FILIPOW N, Davies G, Main E, Sebire NJ, et al
    Unsupervised phenotypic clustering for determining clinical status in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    >> Share

    July 2021
  5. DELACOURT C, Bertille N, Salomon LJ, Rashenas M, et al
    Predicting the risk of respiratory distress in newborns with congenital pulmonary malformations.
    Eur Respir J. 2021 Jul 15. pii: 13993003.00949-2021.
    >> Share

  6. MESSIKA J, Bunel V, Weisenburger G, Godet C, et al
    Pseudomonas aeruginosa eradication after lung transplantation: is it the tip of the iceberg?
    Eur Respir J. 2021;58.
    >> Share

  7. STAHL M
    Sensitive markers to detect progression of lung disease in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    >> Share

  8. STANOJEVIC S, Davis SD, Perrem L, Shaw M, et al
    Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    >> Share

  9. FRAUCHIGER BS, Binggeli S, Yammine S, Spycher B, et al
    Longitudinal course of clinical lung clearance index in children with cystic fibrosis.
    Eur Respir J. 2021;58.
    >> Share

    June 2021
  10. VANHAVERBEKE K, Slaats M, Al-Nejar M, Everaars N, et al
    Functional respiratory imaging provides novel insights into the long-term respiratory sequelae of bronchopulmonary dysplasia.
    Eur Respir J. 2021;57.
    >> Share

  11. HAGNER M, Albrecht M, Guerra M, Braubach P, et al
    IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease.
    Eur Respir J. 2021;57.
    >> Share

  12. LASELVA O, Bartlett C, Gunawardena TNA, Ouyang H, et al
    Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator.
    Eur Respir J. 2021;57.
    >> Share

  13. GILLAN JL, Davidson DJ, Gray RD
    Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages.
    Eur Respir J. 2021;57.
    >> Share

    May 2021
  14. STEWART S, Chan YK, Playford D, Strange GA, et al
    Mild pulmonary hypertension and premature mortality among 154 956 men and women undergoing routine echocardiography.
    Eur Respir J. 2021 May 28. pii: 13993003.00832-2021.
    >> Share

  15. HUGHES DA, Bokobza I, Carr SB
    Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis.
    Eur Respir J. 2021;57.
    >> Share

    April 2021
  16. COSIN-TOMAS M, Bustamante M, Sunyer J
    Epigenetic association studies at birth and the origin of lung function development.
    Eur Respir J. 2021;57.
    >> Share

  17. MUNIDASA S, Couch MJ, Rayment JH, Voskrebenzev A, et al
    Free-breathing MRI for monitoring ventilation changes following antibiotic treatment of pulmonary exacerbations in paediatric cystic fibrosis.
    Eur Respir J. 2021;57.
    >> Share

  18. DECLERCQ M, de Zeeuw P, Conchinha NV, Geldhof V, et al
    Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype.
    Eur Respir J. 2021;57.
    >> Share

  19. BARTELL JA, Sommer LM, Marvig RL, Skov M, et al
    Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.
    Eur Respir J. 2021;57.
    >> Share

    March 2021
  20. AGUSTI A, Breyer-Kohansal R, Faner R
    Transitioning from infancy to adulthood: a black box full of opportunities.
    Eur Respir J. 2021;57.
    >> Share

    February 2021
  21. O'SHEA KM, O'Carroll OM, Carroll C, Grogan B, et al
    Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease.
    Eur Respir J. 2021;57.
    >> Share

    January 2021
  22. HARDISTY GR, Law SM, Carter S, Grogan B, et al
    Ivacaftor modifies cystic fibrosis neutrophil phenotype in subjects with R117H residual function CFTR mutations.
    Eur Respir J. 2021;57.
    >> Share

  23. RAMALHO AS, Furstova E, Vonk AM, Ferrante M, et al
    Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis.
    Eur Respir J. 2021;57.
    >> Share

  24. BENGTSON CD, Kim MD, Anabtawi A, He J, et al
    Hyperglycaemia in cystic fibrosis adversely affects BK channel function critical for mucus clearance.
    Eur Respir J. 2021;57.
    >> Share

    November 2020
  25. MUKHERJEE N, Arathimos R, Chen S, Kheirkhah Rahimabad P, et al
    DNA methylation at birth is associated with lung function development till age 26 years.
    Eur Respir J. 2020 Nov 19. pii: 13993003.03505-2020.
    >> Share

    September 2020
  26. MARTIN C, Burgel PR
    Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?
    Eur Respir J. 2020;56.
    >> Share

    May 2020
  27. ERICSSON AC
    Bronchopulmonary dysplasia: a crime of opportunity?
    Eur Respir J. 2020;55.
    >> Share

  28. RANG C, Keating D, Wilson J, Kotsimbos T, et al
    Re-imagining cystic fibrosis care: next generation thinking.
    Eur Respir J. 2020;55.
    >> Share

  29. TURKOVIC L, Caudri D, Rosenow T, Breuer O, et al
    Structural determinants of long-term functional outcomes in young children with cystic fibrosis.
    Eur Respir J. 2020;55.
    >> Share

    April 2020
  30. POLLAK M, Shaw M, Wilson D, Grasemann H, et al
    Bronchodilator Responsiveness in Children with Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis.
    Eur Respir J. 2020 Apr 8. pii: 13993003.00175-2020.
    >> Share

  31. KENTGENS AC, Oppelaar M, Merkus P
    A new breeze from an inspiring past: normality with multiple breath washout in school-aged children.
    Eur Respir J. 2020;55.
    >> Share

  32. FLUME PA, VanDevanter DR
    Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes.
    Eur Respir J. 2020;55.
    >> Share

    November 2018
  33. SKOPELJA-GARDNER S, Theprungsirikul J, Meagher RE, Beliveau CM, et al
    Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response.
    Eur Respir J. 2018 Nov 1. pii: 13993003.01891-2018.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016